Close

Hmmm, you are using a Gmail.com email address...

Google has declared war on the independent media and has begun blocking emails from NaturalNews from getting to our readers. We recommend GoodGopher.com as a free, uncensored email receiving service, or ProtonMail.com as a free, encrypted email send and receive service.

That's okay. Continue with my Gmail address...

Cancer’s worst enemy: Curcumin powerfully influences cell metabolic activity in cancer tumors


Curcumin influences cell metabolic activity vitality in various cancer phenotypes. The nutrient, which is abundant in turmeric, was observed to have remarkable abilities in modulating the regression of carcinoma in the thyroid gland. This new research, published in BMC Complementary and Alternative Medicine shows the potential of curcumin as a safe and natural treatment option for cancer.

  • Three different types of extracts of the rhizome, Curcuma longa L. were collected.
  • All turmeric extracts were provided by Biosalus Company in Naples, Italy.
  • The percentage of curcumin found in the extracts were at 65, 80, and 87 percent, respectively.
  • These extracts were tested on a validated model of human papillary thyroid cancer.
  • A comparison among the three extracts showed that a higher percentage of curcumin was most effective in inhibiting cancer growth — though there was no great difference among the three.
  • All extracts displayed profound antioxidant and anti-inflammatory effects, even after 48 hours of treatment.

Authors of the study concluded that curcumin is a potent agent in cancer management and treatment. They likewise hypothesize using the nutrient in treating various disorders related to the central nervous system, such as Alzheimer’s and Parkinson’s.

The full text of the study can be found at this link.

To read more stories on how to nip cancer in the bud, visit PreventCancer.news today.

Journal Reference:

Perna, A., de Luca, A., Adelfi, L., Pasquale, T., Varriale, B., & Esposito, T. EFFECTS OF DIFFERENT EXTRACTS OF CURCUMIN ON TPC1 PAPILLARY THYROID CANCER CELL LINE. BMC Complementary and Alternative Medicine, 2018; 18:63 DOI: 10.1186/s12906-018-2125-9

Receive Our Free Email Newsletter

Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.



Comments
comments powered by Disqus

RECENT NEWS & ARTICLES